Iovance Biotherapeutics logo

Iovance Biotherapeutics share price today

(NASDAQ: IOVA)

Iovance Biotherapeutics share price is $6.19 & ₹535.37 as on 24 Jan 2025, 2.30 'hrs' IST

$6.19

0.2

(3.34%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Iovance Biotherapeutics share price in Dollar and Rupees. Guide to invest in Iovance Biotherapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Iovance Biotherapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Iovance Biotherapeutics share price movements

  • Today's Low: $5.71
    Today's High: $6.20

    Day's Volatility :7.87%

  • 52 Weeks Low: $5.57
    52 Weeks High: $18.33

    52 Weeks Volatility :69.61%

Iovance Biotherapeutics Returns

PeriodIovance Biotherapeutics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-43.86%
-5.5%
0.0%
6 Months
-35.24%
-4.3%
0.0%
1 Year
-21.6%
1.6%
0.0%
3 Years
-59.14%
9.8%
-11.0%

Iovance Biotherapeutics Key Statistics

in dollars & INR

Previous Close
$5.99
Open
$5.9
Today's High
$6.1976
Today's Low
$5.71
Market Capitalization
$1.8B
Today's Volume
$8.3M
52 Week High
$18.33
52 Week Low
$5.57
Revenue TTM
$90.9M
EBITDA
$-408.3M
Earnings Per Share (EPS)
$-1.48
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-56.65%

How to invest in Iovance Biotherapeutics Stock (IOVA) from India?

It is very easy for Indian residents to invest directly in Iovance Biotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Iovance Biotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Iovance Biotherapeutics or IOVA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Iovance Biotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Iovance Biotherapeutics shares which would translate to 0.140 fractional shares of Iovance Biotherapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Iovance Biotherapeutics, in just a few clicks!

Returns in Iovance Biotherapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Iovance Biotherapeutics investment value today

Current value as on today

₹85,075

Returns

₹14,925

(-14.92%)

Returns from Iovance Biotherapeutics Stock

₹18,979 (-18.98%)

Dollar Returns

₹4,054 (+4.05%)

Indian investors sentiment towards Iovance Biotherapeutics

71.43%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Investment in Iovance Biotherapeutics from India has grown in the last 30 days as on Jan 24, 2025. 71.43% more purchase transactions for Iovance Biotherapeutics in the last 30 days versus the previous period.

12%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Iovance Biotherapeutics on INDmoney from India has grown in the last 30 days as on Jan 24, 2025. 12% more investors are searching Iovance Biotherapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Iovance Biotherapeutics

  • Vanguard Group Inc

    8.96%

  • Perceptive Advisors LLC

    8.73%

  • Mhr Fund Management Llc

    7.87%

  • BlackRock Inc

    7.05%

  • State Street Corp

    4.33%

  • Soleus Capital Management, L.P.

    2.80%

Analyst Recommendation on Iovance Biotherapeutics

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 20 Wall street analysts offering stock ratings for Iovance Biotherapeutics(by analysts ranked 0 to 5 stars)

Based on 20 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
18
18
18
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Iovance Biotherapeutics

What analysts predicted

Upside of 283.99%

Target:

$23.77

Current:

$6.19

Insights on Iovance Biotherapeutics

  • Price Movement

    In the last 1 month, IOVA stock has moved down by -19.7%
  • IOVA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 40.5% return, outperforming this stock by 63.5%
  • IOVA vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 95.4% return, outperforming this stock by 152.5%
  • Price to Sales

    ForIOVA every $1 of sales, investors are willing to pay $18.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.1 for every $1 of sales.

Iovance Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Iovance Biotherapeutics is currently in a neutral trading position according to technical analysis indicators.

Iovance Biotherapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Iovance Biotherapeutics, Inc. logo
-21.18%
-35.24%
-21.6%
-59.14%
-72.32%
Biontech Se logo
0.91%
34.01%
18.85%
-26.4%
246.9%
Regeneron Pharmaceuticals, Inc. logo
-4.82%
-36.95%
-28.33%
12.74%
100.35%
Vertex Pharmaceuticals Incorporated logo
4.86%
-13.58%
-0.46%
88.45%
88.24%
Alnylam Pharmaceuticals, Inc. logo
9.57%
13.5%
44.91%
103.56%
127.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Iovance Biotherapeutics, Inc. logo
NA
NA
0.0
-1.29
-0.57
-0.29
NA
2.54
Biontech Se logo
160.8
NA
0.04
-3.33
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
17.02
17.02
1.05
44.99
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.1
0.48
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Iovance Biotherapeutics, Inc. logo
Buy
$1.8B
-72.32%
NA
0.0%
Biontech Se logo
Buy
$28.1B
246.9%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$75.6B
100.35%
17.02
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$110.2B
88.24%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$34.2B
127.75%
NA
-15.86%

Iovance Biotherapeutics Dividend announcements

  • Iovance Biotherapeutics Earnings

    Iovance Biotherapeutics’s price-to-earnings ratio stands at None

    Read More

About Iovance Biotherapeutics

Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic renal cell carcinoma. It also develops lifileucel in combination with pembrolizumab to treat frontline advanced melanoma patients; LN-145 for the treatment of non-small cell lung cancer (NSCLC) and solid tumor cancers; IOV-4001, which is in Phase 1/2 IOV-GM1-201 clinical trial, for the treatment of NSCLC; and lifileucel for gynecological cancers. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc.; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.D. Anderson Cancer Center; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.
Organization
Iovance Biotherapeutics
Employees
557
CEO
Dr. Frederick G. Vogt Esq., J.D., Ph.D.
Industry
Health Technology

Management People of Iovance Biotherapeutics

NameTitle
Dr. Frederick G. Vogt Esq., J.D., Ph.D.
Interim CEO, President, General Counsel, Corporate Secretary & Director
Mr. Jean-Marc Bellemin M.B.A.
CFO, Principal Accounting Officer & Treasurer
Dr. Igor P. Bilinsky Ph.D.
Chief Operating Officer
Dr. Friedrich Graf Finckenstein M.D.
Chief Medical Officer
Ms. Sara Pellegrino
Vice President of Investor Relations & Public Relations
Ms. Tracy Winton
Executive Vice President of Human Resources
Mr. Howard B. Johnson M.B.A.
Chief Business Officer
Dr. Raj K. Puri M.D., Ph.D.
Chief Regulatory Officer
Mr. Brian Shew M.B.A.
Senior VP & Head of Digital and Information Technology
Mr. Kevin Smyth
Executive Vice President of Quality

Important FAQs about investing in Iovance Biotherapeutics (IOVA) from India :

What is Iovance Biotherapeutics share price today?

Iovance Biotherapeutics share price today stands at $6.19, Open: $5.90 ; Previous Close: $5.99 ; High: $6.20 ; Low: $5.71 ; 52 Week High: $18.33 ; 52 Week Low: $5.57. The stock opens at $5.90, after a previous close of $5.99. The stock reached a daily high of $6.20 and a low of $5.71, with a 52-week high of $18.33 and a 52-week low of $5.57.

Can Indians buy Iovance Biotherapeutics shares?

Yes, Indians can invest in the Iovance Biotherapeutics (IOVA) from India.

With INDmoney, you can buy Iovance Biotherapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Iovance Biotherapeutics at zero transaction cost.

How can I buy Iovance Biotherapeutics shares from India?

It is very easy to buy Iovance Biotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Iovance Biotherapeutics be purchased?

Yes, you can buy fractional shares of Iovance Biotherapeutics with INDmoney app.

What are the documents required to start investing in Iovance Biotherapeutics stocks?

To start investing in Iovance Biotherapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Iovance Biotherapeutics

Today’s highest price of Iovance Biotherapeutics (IOVA) is $6.20.

Today’s lowest price of Iovance Biotherapeutics (IOVA) is $5.71.

What is today's market capitalisation of Iovance Biotherapeutics

Today's market capitalisation of Iovance Biotherapeutics IOVA is 1.8B

What is the 52 Week High and Low Range of Iovance Biotherapeutics

  • 52 Week High

    $18.33

  • 52 Week Low

    $5.57

What are the historical returns of Iovance Biotherapeutics?

  • 1 Month Returns

    -21.18%

  • 3 Months Returns

    -35.24%

  • 1 Year Returns

    -21.6%

  • 5 Years Returns

    -72.32%

Who is the Chief Executive Officer (CEO) of Iovance Biotherapeutics

Dr. Frederick G. Vogt Esq., J.D., Ph.D. is the current Chief Executive Officer (CEO) of Iovance Biotherapeutics.